India is uniquely positioned to withstand the challenges posed by US President Donald Trump’s tariffs and could even outperform its global peers, thanks to a favorable tariff differential, according to Sandeep Tandon, Founder and CIO of Quant Capital.
Tandon believes that Trump’s tariff moves are a bargaining tactic rather than a long-term economic shift, and India’s resilience, driven by its domestic economy, makes it a relative beneficiary.
India has taken proactive steps to counter the tariffs and the uncertainty brought by the US' reciprocal tariff is unlikely to last beyond two quarters, as per Tandon.
Tandon also highlighted India's critical role in the US supply chain for generic drugs and stated that imposing tariffs on Indian pharma imports would only worsen the situation for US citizens.